Dolby Laboratories (DLB)
(Delayed Data from NYSE)
$78.68 USD
+0.31 (0.40%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $78.64 -0.04 (-0.05%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DLB 78.68 +0.31(0.40%)
Will DLB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DLB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DLB
Is the Options Market Predicting a Spike in Dolby Laboratories (DLB) Stock?
Dolby Laboratories (DLB) Signs Deal to Acquire GE Licensing
DLB: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Crocs, PlayAGS, Dolby Laboratories, Netflix and Royal Caribbean Cruises
New Strong Buy Stocks for May 31st
5 Solid Stocks to Buy on Rebound in Consumer Confidence
Other News for DLB
One buy and one sell recommendation from each sector within SMID caps - Oppenheimer
Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2024 Financial Results
Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
What 4 Analyst Ratings Have To Say About Dolby Laboratories
Dolby Laboratories To Acquire GE Licensing In $429M Cash Deal: Strengthens Patent Portfolio